GridAI Technologies (GRDX) Total Debt (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Total Debt came in at $7.9 million in Q2 2026, up 1032.34% on a YoY basis from $700000.0 in Q2 2025, and down 4.24% quarter-over-quarter from $8.3 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Total Debt (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Total Debt for 12 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Debt rose 1032.34% year-over-year to $7.9 million; the trailing twelve-month figure through Jun 2026 stood at $7.9 million (up 1032.34% YoY), and the FY2025 full-year result was $8.3 million, changed N/A from the prior year.
- Total Debt retreated to $7.9 million in Q2 2026 per GRDX's latest filing, from $8.3 million in the prior quarter.
- Across five years, Total Debt topped out at $8.3 million in Q4 2025 and bottomed at $153478.0 in Q2 2023.
- Historically, Total Debt has averaged $2.2 million across 5 years, with a median of $612784.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Total Debt soared 1683.61% in 2024, then plunged 89.68% in 2025.
- Over 5 years, Total Debt stood at $603494.0 in 2022, then advanced by 1.54% to $612784.0 in 2023, then sank by 71.02% to $177563.0 in 2024, then soared by 4561.55% to $8.3 million in 2025, then decreased by 4.24% to $7.9 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $7.9 million, $8.3 million, and $2.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 7.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.93 Mn |
| Dec 31, 2025 | 8.28 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Jun 30, 2024 | 177,563.00 |
| Mar 31, 2024 | 6.78 Mn |
| Dec 31, 2023 | 612,784.00 |
| Jun 30, 2023 | 153,478.00 |
| Mar 31, 2023 | 380,390.00 |
| Dec 31, 2022 | 603,494.00 |
| Jun 30, 2022 | 161,909.00 |
| Mar 31, 2022 | 402,766.00 |
| Dec 31, 2021 | 641,236.00 |
| Jun 30, 2021 | 279,138.00 |
| Mar 31, 2021 | 694,164.00 |
| Dec 31, 2020 | 1.10 Mn |
| Sep 30, 2020 | 38,453.00 |
| Jun 30, 2020 | 622,462.00 |
| Mar 31, 2020 | 956,469.00 |